Strategic Partnerships for Global Impact
Strong & Meaningful Partnerships
Driving Innovation Through Global Partnerships and Networks
At Vactech, we prioritize strong, meaningful partnerships. Our longstanding collaborations with both academia and industry ensure reliable, high-quality results and compatibility with global pharmaceutical standards. Thanks to our leadership’s extensive professional networks, we maintain direct connections with leading scientific communities and influential Key Opinion Leaders worldwide, continually enhancing our innovation capabilities and global reach.
“Vactech’s impressive track record and strategic collaborations with leading pharmaceutical companies, biotech industry partners, and academic institutions have positioned the company at the forefront of preventive solutions for type 1 diabetes. These collaborations have been instrumental in advancing our vaccine candidates into clinical trials. With its innovative approach and strong global partnerships, Vactech clearly stands out as a global leader in the prevention of type 1 diabetes and related conditions.” Petri Laine - Partner, Innovestor Venture Capital
Stronger Together
Cooperation With
Academic Groups
and Industrial Partners
Vactech collaborates closely with leading international academic institutions and industry partners, adhering strictly to Good Laboratory Practices (GLP) and Good Clinical Practices (GCP). Our strong experience in preclinical and clinical research together with established collaboration networks creates a solid basis for effective development of our assets and conduction of preclinical and clinical trials.
